Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Teleflex IncorporatedNYSE: TFX
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income declines year over year
Q2 FY2026 net income of $99.69M fell 18.7% year over year, ahead of the -267.2% change in trailing-twelve-month net income. Over 3 fiscal years it compounded at -45.6% a year.
Context
- Net income amounted to 2.9% of revenue in FY2025, up 0.7 pp from a year earlier.
- Net income increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 9 analysts of $343.28M (+486.5%) for the fiscal year ending Dec 2026, a step up from the -16.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $99.69M+1322.6% QoQ
- Last fiscal yearDec 2025
- $58.53M-16.0% YoY
- LTMJun 2026
- -$320.9M-267.2% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 58.53M USD
- Year-over-year change
- -16.0%
- 4-year CAGR
- -41.1%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 58.53M | -16.0% |
| FY2024 | 2024-12-31 | 69.68M | -80.4% |
| FY2023 | 2023-12-31 | 356.33M | -1.9% |
| FY2022 | 2022-12-31 | 363.14M | -25.2% |
| FY2021 | 2021-12-31 | 485.37M | — |
Net Income vs competitors
How TFX compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -267.2% is the 10th highest of 11, against a peer median of -21.5%.
- Net income amounts to 12.3% of revenue for TFX, versus a peer median of 11.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.38B USD | +152.9% | +50.8% | — | |
| LTM Sep 2026 | $717.13M USD | -2481.4% | +50.8% | 159.1% | |
| LTM Sep 2026 | $456.14M USD | -6.6% | -3.6% | 1812.1% | |
| LTM Jun 2026 | $320.9M USD | -267.2% | -45.6% | 12.3% | |
| LTM Jun 2026 | $241.47M USD | +64.6% | — | 54.8% | |
| LTM Jun 2026 | €173.64M EUR | -3.3% | -10.5% | 14.2% | |
| LTM Jun 2026 | $167M USD | -36.5% | — | 3.1% | |
| LTM Sep 2026 | $160.12M USD | +35.2% | +19.9% | 9.9% | |
| LTM Sep 2026 | $106.06M USD | -76.3% | — | 11.8% | |
| LTM Jun 2026 | $38.38M USD | -106.1% | — | 3.8% | |
| LTM Sep 2026 | $351K USD | -100.1% | — | 0.0% | |
| Peer median (excluding TFX) | — | -21.5% | +19.9% | 11.8% | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 485.37M | 363.14M | 356.33M | 69.68M | 58.53M |
| Depreciation & Amortization | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M |
| Deferred Income Tax | (110.24M) | (13.01M) | (13.05M) | 0 | (100.97M) |
| Stock-Based Compensation | 22.94M | 27.22M | 31.47M | 31.35M | 0 |
| Change in Working Capital | 127.35M | (239.96M) | (111.77M) | (1.82M) | (81.09M) |
| Accounts Receivables | (600K) | (38.46M) | (15.76M) | (27.95M) | (85.53M) |
| Inventory | (11.14M) | (110.69M) | (41.07M) | 1.72M | 84.04M |
| Accounts Payables | 94.02M | (24.79M) | (31.26M) | 9.67M | (8.28M) |
| Other Working Capital | 45.06M | (66.03M) | (23.68M) | 14.74M | (71.31M) |
| Other Non-Cash Items | (111.36M) | (25.84M) | 5.55M | 261.94M | 286.46M |
| Operating Cash Flow | 651.42M | 342.14M | 510.64M | 635.74M | 340.68M |
| Capital Expenditures | (71.62M) | (79.19M) | (91.44M) | (126.43M) | (95.24M) |
| Acquisitions (Net) | 220.32M | (186M) | (588.92M) | (120K) | (825.15M) |
| Purchases of Investments | (18.42M) | (22.3M) | (11.3M) | (7.3M) | (5M) |
| Sales of Investments | 7.3M | 7.3M | 7.3M | 7.3M | 0 |
| Other Investing Activities | 19.15M | 22.24M | 63.13M | 27.2M | 76.19M |
| Investing Cash Flow | 156.74M | (257.94M) | (621.23M) | (99.36M) | (849.19M) |
| Debt Repayment | (634.5M) | (145.45M) | 101.25M | (161.5M) | 982.04M |
| Common Stock Issued | 11.1M | 4.31M | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (4.31M) | 0 | (200M) | (300M) |
| Dividends Paid | (63.65M) | (63.79M) | (63.9M) | (63.54M) | (60.27M) |
| Other Financing Activities | (28.77M) | (8.27M) | 1.19M | 3.12M | (10.23M) |
| Financing Cash Flow | (715.82M) | (217.51M) | 38.54M | (421.93M) | 611.54M |
| Effect of Forex Changes | (23.13M) | (19.74M) | 2.86M | (9.65M) | (29.35M) |
| Net Change in Cash | 69.2M | (153.05M) | (69.19M) | 104.8M | 73.68M |
| Free Cash Flow | 579.8M | 262.95M | 419.2M | 509.31M | 245.44M |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.